Article Information
History
- January 26, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Tianyang Mao1,*,
- Benjamin Israelow1,2,*,#,
- Alexandra Suberi3,
- Liqun Zhou1,
- Melanie Reschke4,
- Mario A Peña-Hernández1,
- Huiping Dong1,
- Robert J. Homer5,
- W. Mark Saltzman3 and
- Akiko Iwasaki1,6,#
- 1Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
- 2Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA
- 3Department of Biomedical Engineering, Yale University, New Haven, CT, USA
- 4Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, USA
- 5Department of Pathology, Yale University School of Medicine, CT, USA
- 6Howard Hughes Medical Institute, Chevy Chase, MD, USA
- ↵#Corresponding: Benjamin Israelow (benjamin.goldman-israelow{at}yale.edu) and Akiko Iwasaki (akiko.iwasaki{at}yale.edu)
↵* Equal contribution: Tianyang Mao and Benjamin Israelow
Posted January 26, 2022.
Unadjuvanted intranasal spike vaccine booster elicits robust protective mucosal immunity against sarbecoviruses
